Cited by 399Cancer-related Molecular PathwaysGenomics and Chromatin DynamicsDevelopmental Biology and Gene Regulation

The RUNX family: developmental regulators in cancer

Ito, Yoshiaki, Bae, Suk-Chul, Chuang, Linda Shyue Huey·2015·Nature Reviews Cancer

Abstract

RUNX proteins belong to a family of metazoan transcription factors that serve as master regulators of development. They are frequently deregulated in human cancers, indicating a prominent and, at times, paradoxical role in cancer pathogenesis. The contextual cues that direct RUNX function represent a fast-growing field in cancer research and could provide insights that are applicable to early cancer detection and treatment. This Review describes how RUNX proteins communicate with key signalling pathways during the multistep progression to malignancy; in particular, we highlight the emerging partnership of RUNX with p53 in cancer suppression.

Integrity signals

Registry

Crossref · 10.1038/nrc3877

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ito, Y., Bae, S.-C., & Chuang, L. S. H.
Affiliations
  • National University of Singapore (SG)
  • Chungbuk National University (KR)
Corresponding author
Ito, Yoshiaki
Venue
Nature Reviews Cancer
Published
2015-01-16
Volume
15
Issue
2
Pages
81-95
ISSN
  • 1474-175X (ISSN-L)
  • 1474-1768
OpenAlex
W2131110612
Cited by
399
References
8
Citations by year
2026: 21 · 2025: 20 · 2024: 32 · 2023: 49 · 2022: 34 · 2021: 37 · 2020: 46 · 2019: 25 · 2018: 35 · 2017: 50 · 2016: 30 · 2015: 20
FWCI
4.79
Type
journal article
Language
en
Open access
closed
Locations
  • Nature reviews. Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • National University of Singapore (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Keywords
Runx transcription factors, cancer, tumour suppressor, oncogenic transcription factor, developmental regulation, signaling pathways, p53, tumor progression, early cancer detection, cancer therapy
MeSH terms
Cell Differentiation, DNA Damage, DNA Repair, Humans, Inflammation, Neoplasms, Phosphorylation, Transcription, Genetic, Signal Transduction, Tumor Suppressor Protein p53, Cyclin-Dependent Kinases, DNA Methylation, ADP-Ribosylation Factors, Cell Proliferation, Core Binding Factor alpha Subunits

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review